Transient transfection of insect Sf-9 cells in TubeSpin®bioreactor 50 tubes
© Shen et al; licensee BioMed Central Ltd. 2011
Published: 22 November 2011
Sf-9 cells, derived from Spodoptera frugiperda, are widely used for recombinant protein production using the baculovirus expression vector system (BEVS). However, this results in a productive viral infection and cell lysis. Therefore, a non-lytic, plasmid-based expression system for suspension Sf-9 cells would be a valuable alternative to the BEVS for rapid, scalable, and high-yielding recombinant protein production and for the generation of stable Sf-9 cell lines . In this work, we present a simple, efficient and cost-effective plasmid-based method for transient expression of recombinant proteins in Sf-9 cells cultivated in serum-free suspension mode in a high-throughput culture system, TubeSpin® bioreactor 50 tubes (TubeSpins).
Materials and methods
Sf-9 cells were maintained in suspension in TubeSpins (TPP, Trasadingen, Switzerland) at 28 °C . The human tumor necrosis factor receptor-Fc fusion protein (TNFR-Fc) gene was cloned into pIEx10 (Novagen, Merck, Darmstadt, Germany) to generate pIEx-TNFR-Fc. The cells in exponential growth phase were inoculated in fresh Sf900 II medium (Invitrogen, Carlsbad, CA) one day prior to transfection. The next day, the cells were transfected with 1.5 µg pTNFR-Fc and 2.25 µg linear 25 kDa polyethylenimine (PEI, Polysciences, Warrington, PA) per 106 cells. The DNA and PEI were first mixed in de-ionized water at room temperature for 10 min prior to addition to the culture. At the time of transfection the cell density was 20 x 106 cells per mL. Cells were subsequently diluted to 4 x 106 cells per mL with fresh Sf900 II media to allow for growth. The culture was maintained at 28 °C in an incubator shaker for 7 d . The TNFR-Fc concentration in the medium was determined by ELISA as described .
This study validates the use of PEI for transient expression in suspension Sf-9 cell cultures. This system was used to produce both intracellular (GFP) and secreted (TNFR-Fc) proteins. The results show that PEI-mediated transient transfection is a fast and efficient alternative to BEVS for high-yielding protein expression in Sf-9 cells.
This work has been supported by the CTI Innovation Promotion Agency of the Swiss Federal Department of Economic Affairs, by grants from the Guangdong Provincial Department of Science and Technology (2008B030301349), the MOE of China (211 Grant), and the Academy of Finland (decision no. 135820). TPP (Trasadingen, Switzerland) is acknowledged for providing TubeSpin® bioreactor 50 tubes.
- De Jesus M, Wurm FM: Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors. Eur J Pharm Biopharm. 2011, 78: 184-188. 10.1016/j.ejpb.2011.01.005.View ArticlePubMedGoogle Scholar
- Harrison RL, Jarvis DL: Transforming lepidopteran insect cells for continuous recombinant protein expression. Methods Mol Biol. 2007, 388: 299-316. 10.1007/978-1-59745-457-5_15.View ArticlePubMedGoogle Scholar
- Jarvis DL: Baculovirus-insect cell expression systems. Methods Enzymol. 2009, 463: 191-222.View ArticlePubMedGoogle Scholar
- Li E, Brown SL, Dolman CS, Brown GB, Nemerow GR: Production of functional antibodies generated in a nonlytic insect cell expression system. Prot Expr Purif. 2001, 21: 121-128. 10.1006/prep.2000.1329.View ArticleGoogle Scholar
- Xie Q, Michel PO, Baldi L, Hacker DL, Zhang X, Wurm FM: TubeSpin bioreactor 50 for the high-density cultivation of Sf-9 insect cells in suspension. Biotechnol Lett. 2011, 33: 897-902. 10.1007/s10529-011-0527-6.View ArticlePubMedGoogle Scholar
- Oberbek A, Matasci M, Hacker DL, Wurm FM: Generation of stable, high-producing CHO cell lines by lentiviral vector-mediated gene transfer in serum-free suspension culture. Biotechnol Bioeng. 2011, 108: 600-610. 10.1002/bit.22968.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.